Hydrogen sulfide promotes the stemness of liver cancer stem cells through the Wnt/β-catenin signaling pathway

Author:

Liu Bihan1,Wang Shanshan2,Sun Rui1,Ding Huiguo1,Li Lei1

Affiliation:

1. Capital Medical University

2. Beijing Institute of Hepatology, Capital Medical University

Abstract

Abstract Background LCSCs is a key factor in the occurrence and development of HCC. Hydrogen sulphide (H2S) is the third gas signalling molecule after carbon monoxide (CO) and nitrogen monoxide (NO). Exogenous H2S has been shown to inhibit the progression of HCC by increasing apoptosis and autophagy. However, whether H2S can affect LCSCs in HCC microenvironment still remains poorly understand. Methods In vitro, Flow cytometry (FCM), imaging quantitive flow cytometry, RNA-sequencing, and Tumor sphere-forming assay were carried out in the HCC cells and LCSCs to investigate the effect of H2S on biological functions and Wnt/β-catenin signaling pathway. Data was analyzed using unpaired Student's t-test and nonlinear regression. P < 0.05 was considered to indicate a statistically significant difference. Results Based on the FCM, we found that exogenous H2S were able to induce HCC cells apoptosis and promote stemness in HCC cells. RNA-sequencing, imaging quantitive flow cytometry showed that 23 genes was regulated in NaHS group, and NaHS can activate the Wnt/β-catenin signaling pathway in HCC cell lines. Treatment with the Wnt/β-catenin signaling inhibitor ICRT3 alleviated the NaHS-induced stemness increase in HepG2 and Hep3B cells. Furthermore, the tumor sphere-forming assay show that the number of sphere-forming cells was significantly increased in NaHS treated group and was inhibited significantly in ICRT3 treated group. Conclusion Exogenous H2S increased the expression of CD133, CD44 and β-catenin and promoted the stemness in LCSCs by activating the Wnt/β-catenin signalling, which strongly clarify the relationship between Exogenous H2S and LCSC stemness and may provide theoretical guidance and potential therapeutic approaches for liver cancer.

Publisher

Research Square Platform LLC

Reference30 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA: a cancer journal for clinicians,2021

2. Percutaneous Ablation for Hepatocellular Carcinoma;Weinstein JL;AJR American journal of roentgenology,2018

3. Hepatocellular Carcinoma: The Role of Interventional Oncology;Donadon M;Liver cancer,2016

4. Hepatocellular carcinoma. Nature reviews Disease primers 2021, 7(1):7.

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: a cancer journal for clinicians,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3